Astera Labs (NASDAQ:ALAB) Announces Quarterly Earnings Results

Astera Labs (NASDAQ:ALAB - Get Free Report) released its quarterly earnings results on Monday. The company reported $0.10 EPS for the quarter, missing analysts' consensus estimates of $0.26 by ($0.16), Zacks reports. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. Astera Labs updated its Q1 2025 guidance to 0.280-0.290 EPS.

Astera Labs Trading Up 0.8 %

Shares of NASDAQ ALAB traded up $0.69 during mid-day trading on Thursday, hitting $88.19. 6,127,745 shares of the stock traded hands, compared to its average volume of 5,548,214. Astera Labs has a 52 week low of $36.22 and a 52 week high of $147.39. The stock has a fifty day moving average price of $121.35 and a 200-day moving average price of $82.90.

Insider Activity at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 197,297 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the completion of the sale, the director now owns 6,148 shares of the company's stock, valued at $556,455.48. This trade represents a 96.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Philip Mazzara sold 2,513 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.81, for a total transaction of $228,205.53. Following the sale, the general counsel now directly owns 248,745 shares of the company's stock, valued at $22,588,533.45. This trade represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 846,452 shares of company stock worth $86,427,256 over the last ninety days.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on ALAB shares. Northland Capmk upgraded Astera Labs from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 28th. Northland Securities raised Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 price objective on the stock in a report on Tuesday, January 28th. Morgan Stanley lowered their price target on Astera Labs from $142.00 to $114.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 28th. Citigroup assumed coverage on Astera Labs in a report on Monday, November 18th. They issued a "buy" rating and a $120.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on Astera Labs from $60.00 to $100.00 and gave the company a "buy" rating in a report on Tuesday, November 5th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $115.33.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.